MEDIA ALERT
Tampa, Florida (December 2015) – The Boards of Directors of the Celma Mastry Ovarian Cancer Foundation and Ovacome USA are pleased to announce the completion of their unified goal of becoming one voice in their fight for awareness of the symptoms and support for gynecologic cancer patients in the Tampa Bay area.
“Ovarian cancer affects 1 in 75 women of all ages making it vastly important that we maximize our resources and support”, says Claudette Carlan, Chair of the Ovarian Cancer Foundation. “Unfortunately, 75% to 80% are diagnosed in advanced stages greatly limiting life expectancy. This statistic has not changed in 20 years. This statistic can only change through improved funding for ovarian cancer research and the education of women about the risks and subtle symptoms.”
“This is a powerful merger to become one source of emotional support, awareness and advocacy for those in need. We will continue to bring you the focus of our Missions, finding a cure for ovarian cancer and assisting those affected by this deadly disease”, says Kim Snyder, Ovacome President.
Celma Mastry Ovarian Cancer Foundation (CMOCF) and Ovacome, both all-volunteer 501(c)(3) nonprofits, are dedicated to saving lives by educating womene in the community about the symptoms of this deadly cancer that is often diagnosed at later stages. Monthly support group meetings in Pinellas and Hillsborough Counties will continue to be offered for survivors to share their support and experiences with other patients, caregivers and their families. Additional resources are available including a telephone support line, direct financial aid to qualified patients, outreach in communities and a comprehensive website.
The merged Foundation will continue the groups’ partner membership with the Ovarian Cancer National Alliance, a leader in supporting ovarian and other gynecologic patients, with programs including Advocacy Days in Congress, and Survivors Teaching Students in health care professions.